Compare
Abbott Laboratories vs AdaptHealth (ABT vs AHCO)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Abbott Laboratories (ABT) returned -11.7% and AdaptHealth (AHCO) -29.1%; so far this year the figures are -12.3% and -26.4%.
Abbott Laboratories is the larger company by market value, about 190.4 times the size of AdaptHealth.
Revenue grew +10.0% at ABT and +20.7% at AHCO over the last year.
ABT yields 2.29%. AHCO pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| ABT | AHCO | |
|---|---|---|
| Price | $109.93 | $7.33 |
| 1-day | -3.23% | -1.08% |
| YTD | -12.26% | -26.41% |
| 1 year | -11.73% | -29.11% |
| 3 years | +15.70% | +2.37% |
| Market cap | $190.4B | $1.0B |
| P/E | 40.9 | — |
| P/S | 3.95 | 0.28 |
| P/B | 3.73 | 0.82 |
| Revenue growth | +10.00% | +20.70% |
| EPS growth | -66.20% | -632.10% |
| Gross margin % | 56.9 | 15.7 |
| Net margin % | 9.7 | -11.4 |
| ROE % | 9.2 | -33.2 |
| Debt / equity | 0.61 | 1.54 |
| FCF yield % | 3.5 | 8.2 |
| Dividend yield % | 2.29 | — |
| Beta | 0.06 | 0.13 |
| RSI (14) | 58.5 | 71.5 |
| Technical rating |